On March 10, Strategy’s Variable Rate Series A Preferred ($STRC) delivered its most significant trading session since launch. The headline figures are straightforward: $409 million in daily traded volume — the highest on record 3% 30-day volatility — the lowest...
Deploy branded, mobile-optimized signatures across your entire team without usual design or IT bottlenecks. The post Get Unlimited Enterprise-Level Email Signatures for $39 appeared first on TechRepublic. Source link...
Strategy has to pay $689M to not sell any of its BTC, and those costs have increased every quarter since 2021. Source link...
tl;dr Merge progress -- minor spec updates, engineering full steam ahead 🚂No progress in client diversity. Be selfish, run a minority client! Merge update First of all -- fantastic work to all of the engineering teams on the Kintsugi sprint,...
Crypto fintech firm Antalpha is sitting on more than $100 million in unrealized gains after building a large position in tokenized gold, showing rising institutional demand for blockchain-based exposure to bullion. Summary Antalpha’s $241M position in Tether Gold (XAUT) is...
Babylon Labs and Ledger have integrated native hardware signer support to provide secure, trustless bitcoin collateral solutions through a new Clear Signing partnership. Babylon Labs and Ledger announced their partnership on March 10, 2026, to bring Bitcoin Vaults (BTCVaults) to...
Pete Hegseth's department of defense has been burning through money like it's going out of fashion, according to new reporting that claims spending reached $93 billion in September 2025 alone — and items forked out for included everything from $5.3...
It’s alleged that wallets benefiting from the launch of Heart’s HEX, Pulsechain, and/or PulseX are mixing over $500M dollars worth of ETH. Source link...
In our last post, we outlined Devconnect as a week-long gathering that will feature independent Ethereum events, which aim to bring the Ethereum community together in smaller groups to talk, learn about, or make serious progress on specific subjects. Learn...
Inspire therapy—a hypoglossal nerve stimulation implant—has been FDA-approved for more than 11 years, with over 100,000 patients treated across the US, Europe, and Asia. Ruchir Patel, Inspire’s senior medical director, says data show reductions in daytime sleepiness, a 79 percent...
